The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection

Immunology

Volumn 118, Issue 4, 2006, Pages 520-526

  Carr, Daniel J J ^a   Wuest, Todd ^a   Tomanek, Lisa ^a   Silverman, Robert H ^b   Williams, Bryan R G ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CD8+ T cell; Herpes simplex virus type 2; Interferon ; Oligoadenylate synthetases; RNA dependent protein kinase

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CD45 ANTIGEN; PROTEIN KINASE; RNA DEPENDENT PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME DEFICIENCY; FEMALE; GENITAL HERPES; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 2; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION; VAGINA; VAGINITIS; VIRUS TITRATION; WILD TYPE;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIGENS, CD3; BRAIN STEM; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; DISEASE SUSCEPTIBILITY; EIF-2 KINASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; INTERFERON TYPE II; LYMPH NODES; LYMPHOCYTE COUNT; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746050680     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02403.x     Document Type: Article

References (36)

1. Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, St Louis ME. Incidence of herpes simplex virus type 2 in the United States. Am J Epidemiol 2001; 153:912-20.
2. Lafferty W, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infections. Influence of site of infection and viral type. N Engl J Med 1987; 316:1444-9.
3. Milligan GN. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J Virol 1999; 73:6380-6.
4. + T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol 2001; 82:845-53.
5. Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 2003; 77:10168-71.
6. Gill N, Rosenthal KL, Ashkar AA. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol 2005; 79:4470-8.
7. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513-20.
8. Härle P, Noisakran S, Carr DJJ. The application of a plasmid DNA encoding IFN-α1 enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J Immunol 2001; 166:1803-12.
9. Hill AB, Barnett BC, McMichael AJ, McGeoch DJ. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus type 1 and 2. J Immunol 1994; 152:2736-41.
10. Murphy JA, Duerst RJ, Smith TJ, Morrison LA. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 2003; 77:9337-45.
11. Härle P, Cull V, Guo L, Papin J, Lawson C, Carr DJJ. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Res 2002; 56:39-49.
12. Duerst RJ, Morrison LA. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 2004; 322:158-67.
13. Zhou A, Paranjape J, Brown TL et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate synthetase-dependent RNase L. EMBO J 1997; 16:6355-63.
14. Yang YL, Reis LF, Pavlovic J et al. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 1995; 14:6095-106.
15. Zhou A, Der Paranjape JMSD, Williams BRG, Silverman RH. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 1999; 258:435-40.
16. Kaushic C, Ashkar AA, Reid LA, Rosenthal KL. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003; 77:4558-65.
17. McDermott MR, Goldsmith CH, Rosenthal KL, Brais LJ. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J Infect Dis 1989; 159:460-6.
18. Dudley KL, Bourne N, Milligan GN. Immune protection against HSV-2 in B-cell-deficient mice. Virology 2000; 270:454-63.
19. Milligan GN, Bernstein DI. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 1997; 229:259-68.
20. Parr MB, Parr EL. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 1999; 258:282-94.
21. Parr MB, Parr EL. Interferon-γ up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunol 2000; 99:540-5.
22. Svensson A, Nordström I, Sun J-B, Eriksson K. Protective immunity to genital herpes simplex virus type 2 infection is mediated by T-bet. J Immunol 2005; 174:6266-73.
23. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH. A dominant negative mutant of 2-5A-dependent Rnase suppresses antiproliferative and antiviral effects of interferon. EMBO J 1993; 12:3297-304.
24. Der SD, Lau AS. Involvement of the double-stranded RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci USA 1995; 92:8841-5.
25. Fujihara M, Milligan JR, Kaji A. Effect of 2′,5′- oligoadenylate on herpes simplex virus-infected cells and preventive action of 2′,5′-oligoadenylate on the lethal effect of HSV-2. J Interferon Res 1989; 9:691-707.
26. McDermott MR, Smiley JR, Leslie P, Brais J, Rudzroga HE, Bienenstock J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J Virol 1984; 51:747-53.
27. Carr DJJ, Tomanek L, Silverman RH, Campbell IL, Williams BRG. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. J Virol 2005; 79:9341-5.
28. Al-khatib K, Williams BRG, Silverman RH, Halford W, Carr DJJ. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-β-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 2003; 31:126-35.
29. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J Virol 1996; 70:8165-8.
30. + cytotoxic T lymphocyte responses. Proc Natl Acad Sci USA 1997; 94:10289-94.
31. Stuve LL, Brown-Shimer S, Pachl C, Najarian R, Dina D, Burke RL. Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene. J Virol 1987; 61:326-35.
32. Stanberry LR, Bernstein DI, Burke RL, Pachl C, Myers MG. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis 1987; 155:914-20.
33. Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 2001; 166:3451-7.
34. + CTL in persons with frequently recurring genital herpes. J Immunol 2000; 165:1146-52.
35. Lewandowski G, Hobbs M, Geller A. Evidence that deficient IFN-γ production is a biological basis of herpes simplex virus type-2 neurovirulence. J Neuroimmunol 1998; 81:66-75.
36. + T cell function by the IFN-induced and double-stranded RNA-activated kinase PKR. J Immunol 2000; 165:6896-901.